Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with α-streptococci in patients with pustulosis palmaris et plantaris

Clinical and Experimental Immunology

Volumn 157, Issue 1, 2009, Pages 71-82

  Yoshizaki, T ^a   Bandoh, N ^a   Ueda, S ^a   Nozawa, H ^a   Goto, T ^a   Kishibe, K ^a   Takahara, M ^a   Harabuchi, Y ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

streptococci; CC chemokine ligand 20; CC chemokine receptor 6; Pustulosis palmaris et plantaris; Tonsil related disease; Tonsils

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS ANTIGEN ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUSTULOSIS PALMOPLANTARIS; SKIN DEFECT; T LYMPHOCYTE; TONSIL CELL; TONSILLECTOMY; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CHEMOKINE CCL20; CHEMOTAXIS, LEUKOCYTE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PALATINE TONSIL; POSTOPERATIVE PERIOD; PSORIASIS; RECEPTORS, CCR6; SKIN; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; STREPTOCOCCUS; T-LYMPHOCYTES; TONSILLECTOMY; UP-REGULATION;

EID: 66849097965     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03945.x     Document Type: Article

References (43)

1. Andrews GC, Machacek GF. Recalcitrant pustular eruptions of the palms and soles. Arch Dermatol 1934 29 : 548 62.
2. Hellgren L, Mobacken H. Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol 1971 51 : 284 8.
3. Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta Otolaryngol Suppl 1996 523 : 161 4.
4. Ono T. Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris. J Dermatol 1977 4 : 163 72.
5. Yamanaka N, Shido F, Kataura A. Tonsillectomy-induced changes in anti-keratin antibodies in patients with pustulosis palmaris et plantaris: a clinical correlation. Arch Otorhinolaryngol 1989 246 : 109 12.
6. Kuki K, Kimura T, Hayashi Y, Tabata T. Focus tonsils and skin diseases with special reference to palmoplantar pustulosis. Adv Otorhinolaryngol 1992 47 : 196 202.
7. Yokoyama M, Hashigucci K, Yamasaki Y. Effect of tonsillectomy in patients with pustulosis palmaris et plantaris. Acta Otolaryngol 2004 124 : 1109 10.
8. Takahara M, Kishibe K, Nozawa H, Harabuchi Y. Increase of activated T-cells and up-regulation of Smad7 without elevation of TGF-beta expression in tonsils from patients with pustulosis palmaris et plantaris. Clin Immunol 2005 115 : 192 9.
9. Sakiyama H, Kobayashi S, Dianzani U et al. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci 2008 50 : 197 207.
10. Koshiba S, Ichimiya S, Nagashima T et al. Tonsillar crypt epithelium of palmoplantar pustulosis secretes interleukin-6 to support B-cell development via p63/p73 transcription factors. J Pathol 2008 214 : 75 84.
11. Kukuminato Y, Shido F. Investigation of the bacterial flora in the tonsillar lacunae and serum levels of streptococcal antigen-specific antibodies in patients with pustulosis palmaris et plantaris. Nippon Jibiinkoka Gakkai Kaiho 1990 93 : 786 95.
12. Murakata H, Harabuchi Y, Kataura A. Increased interleukin-6, interferon-gamma and tumour necrosis factor-alpha production by tonsillar mononuclear cells stimulated with alpha-streptococci in patients with pustulosis palmaris et plantaris. Acta Otolaryngol 1999 119 : 384 91.
13. Hayashi Y, Kunimoto M, Kuki K, Yamanaka N. Animal model of focal tonsillar infection: human tonsillar lymphocytes induce skin lesion in SCID mice. Acta Otolaryngol Suppl 1996 523 : 193 6.
14. Yamanaka N, Yamamoto Y, Kuki K. Engraftment of tonsillar mononuclear cells in human skin/SCID mouse chimera - validation of a novel xenogeneic transplantation model for autoimmune diseases. Microbiol Immunol 2001 45 : 507 14.
15. Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990 136 : 1053 68.
16. Nozawa H, Kishibe K, Takahara M, Harabuchi Y. Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP). Clin Immunol 2005 116 : 42 53. (Pubitemid 40733582)
17. Fukuoka M, Ogino Y, Sato H et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998 138 : 63 70. (Pubitemid 28077939)
18. Raychaudhuri SP, Jiang WY, Farber EM et al. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999 79 : 9 11. (Pubitemid 29079320)
19. Ozawa M, Terui T, Tagami H. Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris. Dermatology 2005 211 : 249 55.
20. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000 164 : 6621 32.
21. Dieu-Nosjean MC, Massacrier C, Homey B et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000 192 : 705 18.
22. Vanbervliet B, Homey B, Durand I et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 2002 32 : 231 42.
23. Schmuth M, Neyer S, Rainer C et al. Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 2002 11 : 135 42.
24. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001 81 : 335 47.
25. Wakugawa M, Nakamura K, Kakinuma T et al. CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001 117 : 188 96.
26. Teraki Y, Miyake A, Takebayashi R, Shiohara T. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 2004 29 : 658 63.
27. Liao F, Rabin RL, Smith CS et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999 162 : 186 94.
28. Goto T, Bandoh N, Yoshizaki T et al. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol 2008 126 : 260 9.
29. Nomura Y, Abe Y, Ishida Y, Kobayashi H, Harabuchi Y. Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein. J Clin Immunol 2008 28 : 361 9.
30. Clark RA, Chong B, Mirchandani N et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 2006 176 : 4431 9.
31. Asumalahti K, Ameen M, Suomela S et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003 120 : 627 32.
32. Flier J, Boorsma DM, van Beek PJ et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001 194 : 398 405. (Pubitemid 32782663)
33. Yang D, Howard OM, Chen Q, Oppenheim JJ. Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol 1999 163 : 1737 41.
34. Sato K, Kawasaki H, Nagayama H et al. TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol 2000 164 : 2285 95.
35. Ward JM, Barnes RM. HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis. Br J Dermatol 1978 99 : 477 83.
36. Hashigucci K, Yokoyama M, Niizeki H et al. Polymorphism in the tumor necrosis factor B gene is associated with palmoplantar pustulosis. Tissue Antigens 1999 54 : 288 90.
37. Hashigucci K, Niizeki H, Naruse T et al. A clinical feature associated with polymorphisms of the TNF region in Japanese patients with palmoplantar pustulosis. Hum Immunol 2003 64 : 530 7.
38. Francis JN, Sabroe I, Lloyd CM, Durham SR, Till SJ. Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin Exp Immunol 2008 152 : 440 7.
39. Wu Y, Li J. Expression of CC chemokine ligand 20 and CC chemokine receptor 6 mRNA in patients with psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci 2004 24 : 297 9.
40. Kryczek I, Bruce AT, Gudjonsson JE et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008 181 : 4733 41.
41. Nakayama T, Fujisawa R, Yamada H et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001 13 : 95 103. (Pubitemid 32060981)
42. Fernandez TD, Mayorga C, Torres MJ et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008 63 : 712 9.
43. Spiekstra SW, Toebak MJ, Sampat-Sardjoepersad S et al. Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 2005 14 : 109 16.